Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11908-11920
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11908
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11908
Ref. | Gender/ age (yr) | Location | Symptoms/duration | Laboratory testing | Histological findings | Pathogenesis | Surgical treatment | Duration-antibiotics | Outcome |
Suso et al[18], 1988 | M/41 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS | Elevated ESR of 51 mm/h | Tuberculous granuloma, langerhan’s cells | TB | Yes | I + R-9 mo | No recurrence during 3 yr follow-up |
Sugano et al[19], 2000 | M/81 | Flexor tendon sheath | Swelling/24 mo | Normal | giant cell, granuloma | IT | Yes | No | ND |
Ohtani et al[6], 2002 | F/54 | Flexor tendon sheath | Pain, swelling, restricted ROM/12 mo | ND | Chronic nonspecific inflammation | SLE | Yes | No | No recurrence during 1 yr follow-up |
Chau et al[20], 2003 | M/50 | Flexor tendon sheath | Swelling/13 mo | ND | Granuloma, giant cell | NTM | Yes | Anti-tuberculous chemotherapy | Recurrence 5 mo later and re-operation |
M/69 | Flexor tendon sheath | Swelling/13 mo | ND | Granuloma, giant cell | NTM | Yes | Anti-tuberculous chemotherapy | No recurrence | |
F/71 | Flexor tendon sheath | Pain, swelling, CTS/13 mo | ND | Granuloma, giant cell | NTM | Yes | Anti-tuberculous chemotherapy | No recurrence | |
Lee et al[21], 2004 | M/62 | Flexor tendon sheath | Swelling, restricted ROM/30 mo | ND | Granuloma | NTM | Yes | Biaxin | Recurrence 2 yr later and re-operation |
Huang et al[22], 2005 | M/21 | Flexor tendon sheath | Swelling/24 mo | ND | Granuloma, langerhan’s cells | TB | Yes | I + R + E-9 mo | No recurrence during 9 mo follow-up |
Tyllianakis et al[23], 2006 | F/61 | Flexor tendon sheath | Pain, swelling, restricted ROM/6 mo | Elevated ESR of 40 mm/h | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 1 yr follow-up |
Ergun et al[24], 2008 | M/32 | Flexor tendon sheath | Swelling/4 mo | Elevated ESR of 37 mm/h | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 2 yr follow-up |
Teo et al[25], 2008 | F/49 | Flexor tendon sheath | Pain, swelling, restricted ROM/7 mo | Elevated ESR of 36 mm/h | Caseous necrosis | TB | Yes | No | ND |
Nagasawa et al[26], 2009 | M/68 | Flexor tendon sheath | Pain, swelling, restricted ROM/1 mo | Normal | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 5 yr follow-up |
Sanal et al[27], 2009 | M/22 | Flexor tendon sheath | Pain, swelling/30 mo | ND | ND | NTM | Yes | Tetracycline | ND |
Hung et al[28], 2011 | F/56 | Flexor tendon sheath | Pain, swelling/60 mo | Normal | Granuloma | TB | Yes | Anti-tuberculous chemotherapy for 3 mo | No recurrence during 1 yr follow-up |
Iyengar et al[29], 2011 | F/72 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/6 mo | Elevated ESR of 50 mm/h | Fibrinoid necrosis | Serum-negative RA | Yes | No | Recurrence 5 mo later and re-operation |
Woon et al[30], 2011 | M/87 | Flexor tendon sheath | Swelling/14 mo | ND | Granuloma | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 yr follow-up |
M/70 | Flexor tendon sheath | Swelling/14 months | ND | Granuloma | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 yr follow-up | |
F/30 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/14 mo | ND | Tuberculous granuloma, multinucleate giant cell | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 yr follow-up | |
M/44 | Flexor tendon sheath | Swelling/14 mo | ND | Epithelioid granuloma, multinucleate giant cell | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 yr follow-up | |
F/24 | Flexor tendon sheath | Swelling/14 mo | ND | Epithelioid granuloma, multinucleate giant cell, central caseation | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 yr follow-up | |
F/70 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/14 mo | ND | Granuloma, central caseation | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 yr follow-up | |
Chavan et al[31], 2012 | M/57 | Flexor tendon sheath | Pain, swelling/36 mo | Elevated ESR of 45 mm/h | Granuloma, caseous necrosis | TB | Yes | Anti-tuberculous chemotherapy | ND |
Catherine et al[32], 2012 | M/51 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/24 mo | Normal | Granuloma | IT | Yes | No | No recurrence during 1 yr follow-up |
Chan et al[33], 2014 | M/76 | Flexor tendon sheath | Pain, swelling, restricted ROM/12 mo | Elevated ESR of 48 mm/h and CRP of 22.5 mg/L | Chronic nonspecific inflammation | NTM | Yes | CAM + R + E-2 mo | No recurrence during 1.5 yr follow-up |
De Groote et al[34], 2014 | M/69 | Flexor tendon sheath | Pain, swelling, restricted ROM | ND | ND | RA | Yes | No | ND |
Hong et al[35], 2015 | M/80 | Flexor tendon sheath | Swelling/36 mo | Normal | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 1 yr follow-up |
Weber et al[36], 2015 | M/66 | Flexor tendon sheath | Pain, swelling, restricted ROM/6 mo | Elevated CRP of 16 mg/L | Granuloma, giant cell | TB | Yes | I + R-7 mo, P + E-1 mo | No recurrence during 7 mo follow-up |
Bayram et al[37], 2016 | M/50 | Flexor tendon sheath | Pain, swelling, restricted ROM/24 mo | Elevated ESR of 24 mm/h and CRP of 18 mg/L | Granuloma | TB | Yes | Anti-tuberculous chemotherapy for 12 mo | Recurrence 6 mo later and re-operation |
Sbai et al[38], 2016 | M/45 | Extensor tendon sheath | Pain, swelling/6 mo | Elevated ESR of 50 mm/h | Giant cell, granuloma, caseous necrosis | TB | Yes | E + P-2 mo, I + R-8 mo | No recurrence during 2 yr follow-up |
Sulaiman et al[39], 2016 | F/71 | Extensor tendon sheath | Swelling, restricted ROM/36 mo | ND | ND | NTM | Yes | Anti-tuberculous chemotherapy and azithromycin for 9 mo | No recurrence during 9 mo follow-up |
Namkoong et al[40], 2016 | M/76 | Flexor tendon sheath | Tendernerss, swelling/2 mo | ND | Granuloma | NTM | Yes | Anti-tuberculous chemotherapy | Recurrence 12 mo later and re-operation |
Nabet et al[41], 2017 | M/3 | Flexor tendon sheath | pain, swelling, restricted ROM/2 mo | Normal | Chronic nonspecific inflammation | JIA | Yes | NSAID-14 mo | No recurrence during 2.5 yr follow-up |
Yamamoto et al[42], 2017 | M/70 | Flexor tendon sheath | ND | ND | ND | IT | Yes | No | ND |
M/70 | Flexor tendon sheath | ND | ND | Granuloma | NTM | Yes | Anti-tuberculous chemotherapy | Recurrence and re-operation of 2 times during 37 mo follow-up | |
M/53 | Flexor tendon sheath | ND | ND | Granuloma | TB | Yes | Anti-tuberculous chemotherapy | Recurrence 14 mo later and re-operation | |
M/63 | Flexor tendon sheath | ND | ND | Granuloma | TB | Yes | Anti-tuberculous chemotherapy for 12 mo | ND during 1 yr follow-up | |
F/83 | Flexor tendon sheath | ND | ND | Fibrin deposition | Candida | Yes | Anti-tuberculous chemotherapy and CAM | Recurrence 4 mo later and re-operation | |
F/73 | Flexor tendon sheath | ND | ND | Granuloma | NTM | Yes | F-8 mo | No recurrence during 8 mo follow-up | |
M/90 | Flexor tendon sheath | ND | ND | Granuloma | NTM | Yes | F + CAM + E | No recurrence during 6 mo follow-up | |
F/77 | Flexor tendon sheath | ND | ND | Granuloma | NTM | Yes | F + CAM + E | No recurrence during 1 yr follow-up | |
F/80 | Flexor tendon sheath | ND | ND | Granuloma | IT | Yes | F + CAM + E | No recurrence during 6 mo follow-up | |
Baidoo et al[43], 2018 | F/65 | Flexor tendon sheath | pain, swelling, restricted ROM, CTS/24 mo | Elevated ESR of 94 mm/h | Granuloma, langerhan’s cells | TB | Yes | E + P-3 mo, I + R-9 mo | No recurrence during 1 yr follow-up |
Celikyay et al[44], 2018 | M/34 | Flexor tendon sheath | ND | ND | Granuloma, caseous necrosis | TB | Yes | No | ND |
Gupta et al[11], 2018 | F/50 | Flexor tendon sheath | Pain, swelling, restricted ROM/9 mo | Elevated ESR of 50 mm/h | ND | TB | No | Anti-tuberculous chemotherapy for 6 mo | No recurrence during 6 mo follow-up |
Hashimoto et al[45], 2018 | M/79 | Flexor tendon sheath | Swelling/3 mo | ND | Caseous necrosis, langerhan’s cells | TB | Yes | Anti-tuberculous chemotherapy for 2 mo | No recurrence during 1 yr follow-up |
Mohammed Reda et al[46], 2018 | M/69 | Flexor tendon sheath | Pain, swelling, CTS/24 mo | Normal | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 1 yr follow-up |
Saraya et al[47], 2018 | F/74 | Flexor tendon sheath | Swelling, restricted ROM/48 mo | Elevated ESR of 35 mm/h | Granuloma | NTM | Yes | R + E + CAM-6 mo | Recurrence 5 yr later and Remedication for 1.5 yr |
Kurra et al[48], 2019 | F/44 | Extensor tendon sheath | Pain, swelling/12 mo | ND | Chronic nonspecific inflammation | Candida | Yes | No | ND |
Matcuk et al[49], 2020 | F/80 | Flexor tendon sheath | Pain, swelling, restricted ROM/6 mo | Elevated ESR of 65 mm/h | Chronic nonspecific inflammation | NTM | Yes | Azithromycin+ E + moxifloxacin + linezolid | Recurrence 3 mo later and re-operation |
Perţea et al[50], 2020 | F/65 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/2 mo | Normal | Epithelioid granuloma, langerhan’s cells | IT | Yes | No | No recurrence during 30.4 mo follow-up |
F/70 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/4 mo | Normal | Epithelioid granuloma, langerhan’s cells | IT | Yes | No | No recurrence during 30.4 mo follow-up | |
M/56 | Flexor tendon sheath | Swelling/24 mo | Normal | Epithelioid granuloma, langerhan’s cells | IT | Yes | No | No recurrence during 30.4 mo follow-up | |
M/47 | Flexor tendon sheath | Swelling/48 mo | Normal | Epithelioid granuloma, langerhan’s cells | IT | Yes | No | No recurrence during 30.4 mo follow-up | |
Daoussis et al[51], 2021 | F/63 | Flexor tendon sheath | ND | ND | ND | NTM | Yes | Anti-tuberculous chemotherapy | ND |
Tomala et al[52], 2021 | F/86 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/24 mo | ND | Chronic nonspecific inflammation | IT | Yes | No | ND |
Zeng et al[53], 2018 | M/67 | Flexor tendon sheath | Pain, swelling, restricted ROM/24 mo | Elevated CRP of 32.8 mg/L | Chronic nonspecific inflammation | IT | Yes | No | No recurrence |
Li and Zhang et al[54], 2019 | M/55 | Flexor tendon sheath | Pain, swelling, restricted ROM/36 mo | ND | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 3 mo follow-up |
Cheng et al[55], 2020 | M/41 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/0.5 mo | Elevated ESR of 17 mm/h | ND | IT | Yes | No | ND |
Liang et al[56], 2020 | F/45 | Flexor tendon sheath | Pain, swelling, restricted ROM, CTS/24 mo | Normal | Chronic nonspecific inflammation | IT | Yes | No | No recurrence during 1 yr follow-up |
Liu et al[57], 2021 | M/56 | Flexor tendon sheath | Pain, swelling, CTS/24 mo | ND | Prominent acidophilic, amorphous necrotic areas | IT | Yes | No | ND |
Korkmaz et al[58], 2021 | M/42 | Flexor tendon sheath | Pain, swelling/24 mo | Normal | Granulomatous lesions with central necrosis | TB | Yes | Anti-tuberculous chemotherapy | No recurrence during 4 mo follow-up |
- Citation: Tian Y, Zhou HB, Yi K, Wang KJ. Idiopathic tenosynovitis of the wrist with multiple rice bodies: A case report and review of literature. World J Clin Cases 2022; 10(32): 11908-11920
- URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11908.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.11908